Description
This webinar will provide an overview of digital rehabilitative therapy technologies, featuring three vendors who will discuss their care model, the role of this technology in the healthcare pathway, and the role of the PM&R physician.
Learning ObjectivesAfter completing this live activity, the participant should be able to:
- Define digital rehabilitative therapy and its key technological components.
- Describe how digital rehabilitative technologies integrate into the healthcare pathway.
- Identify the role of the PM&R physician within different digital care delivery models.
- Compare vendor approaches to care models and the application of their technologies in clinical practice.
- Recognize key considerations related to implementation, including workflow, billing, and reimbursement.
Principle Faculty
Name, Credential(s): Company Name, Nature of financial relationship;
Thiru Annaswamy, MD, FAAPMR - Nothing to Disclose
Jeffrey Krauss, MD, FAAPMR - Hinge Health
Marc Gruner, DO, MBA, FAAPMR - Limber Health
Jim Fiechtl, MD - Vori Health
AAPM&R Medical Education Committee
Name, Credential(s): Company Name, Nature of financial relationship
Rachel Brakke Holman, MD - Nothing to Disclose
Sarah M. Eickmeyer, MD - Nothing to Disclose
Chelsea D. Frost, MD, MS - Nothing to Disclose
David J. Haustein, MBA,MD,MBA: PM Consulting, Ownership or Partnership; Expert Medical Consulting, Ownership or Partnership; Greene County Medical Society Executive Council, Non-remunerative Positions of Influence; Missouri State Medical Foundation Board, Non-remunerative Positions of Influence; Vice President of the Missouri State Medical Society, Non-remunerative Positions of Influence
Sarah K. Hwang, MD - Nothing to Disclose
Ravi E. Kasi, MD - Nothing to Disclose
Caroline Pupke, DO - Nothing to Disclose
Monica E. Rho, MD - Nothing to Disclose
McCasey R. Smith, MD - Nothing to Disclose
Jennifer A. Soo Hoo, MD - Nothing to Disclose
Brionn K. Tonkin, MD - Nothing to Disclose
Stephanie Tow, MD: US Paralympics Swimming Team Head Physician, Other - Please specify; United States Olympic & Paralympic Committee, Honorarium
Justin L. Weppner, DO - Nothing to Disclose
Alexandra G. Wolfe, DO - Nothing to Disclose
FDA Disclosures
Any faculty member for this activity who intends to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved, will verbally disclose the FDA’s classification at the beginning of their presentation or demonstration.